Abstract:Americans are under assault by a fierce epidemic of obesity, diabetes, and cardiovascular disease, of their own doing. Lowered death rates from heart disease and reduced rates of smoking are seriously threatened by the inexorable rise in overweight and obesity. Latest data indicate that 32% of children are overweight or obese, and fewer than 17% exercise sufficiently. Over 68% of adults are overweight, 35% are obese, nearly 40% fulfill criteria for the metabolic syndrome, 8-13% have diabetes, 34% have hypertension, 36% have prehypertension, 29% have prediabetes, 15% of the population with either diabetes, hypertension, or dyslipidemia are undiagnosed, 59% engage in no vigorous activity, and fewer than 5% of the US population qualifies for the American Heart Association (AHA) definition of ideal cardiovascular health. Health, nutrition, and exercise illiteracy is prevalent, while misinformation and unrealistic expectations are the norm. Half of American adults have at least one cardiovascular risk factor. Up to 65% do not have their conventional risk biomarkers under control. Of those patients with multiple risk factors, fewer than 10% have all of them adequately controlled. Even when patients are treated according to evidence-based protocols, about 70% of cardiac events remain unaddressed. Undertreatment is also common. Poor patient adherence, probably well below 50%, adds further difficulty in reducing cardiovascular risk. Available data indicate that only a modest fraction of the total cardiovascular risk burden in the population is actually now being eliminated. A fresh view of these issues, a change in current philosophy, leading to new and different, multimechanistic methods of prevention may be needed. Adherence to published guidelines will improve substantially outcomes in both primary and secondary prevention. Primordial prevention, which does not allow risk values to appear in a population, affords more complete protection than subsequent partial reversal of elevated risk factors or biomarkers. Current evidence supports recent calls for massive educational programs supporting primordial prevention, individual responsibility and pride in achieving population-wide ideal cardiovascular health through lifestyle modification. Environmental and social changes will be necessary, along with major supportive adjustments in the food industry and the assistance of the media. Cooperation is critical to the success of such an initiative.

Prevention-Key of Controlling Coronary Artery Disease

Leading Prevention and Treatment of Cardiovascular Disease with Scientific Evidence and Management

Recent advances in regulating Lipid Metabolism to prevent Coronary Heart Disease

Early Diagnosis and Strategy for Prevention and Treatment of Coronary Artery Disease

Diabetes: preventing coronary heart disease in a high risk group

Onset of coronary atherosclerotic cardiopathy in diabetes mellitus and its correlative characteristics

Immunomodulatory Mechanism of Coronary Heart Disease and Related Therapeutic Applications and Prospects

Prevention and Control Strategy of Coronary Heart Disease in China

New Progress in Early Diagnosis of Atherosclerosis

Prevention and management of cardiovascular disease risk factors during childhood

Coronary Heart Disease in Type 2 Diabetes: Mechanisms and Comprehensive Prevention Strategies

Dietary Pattern, Lifestyle Factors, and Cardiovascular Diseases

Pathogenesis of coronary atherosclerotic heart disease in coronary artery disease

Thinking on the prevention,treatment and patient rehabilitation of cardiovascular disease in China

Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention

A Survey on Coronary Heart Disease Related Signal Pathways, Drug Targets and Pharmacological Interventions

The role of hydrogen in the prevention and treatment of coronary atherosclerotic heart disease

Advance in dyslipidemia treatment in 2010

Coronary heart disease: Epidemiology and prevention

The Treatment of Coronary Heart Disease: An Update

Recent Advances in the Gut Microbiome and Microbial Metabolites Alterations of Coronary Artery Disease.